Development of Korean Version of Heparin-Coated Shunt.
- Author:
Kyung SUN
1
;
Gee Dong PARK
;
Kwang Jei BAEK
;
Hye Won LEE
;
Jong Won CHOI
;
Seung Chul KIM
;
Taek Chin KIM
;
Sung Yeoll LEE
;
Kwang Taik KIM
;
Hyoung Mook KIM
;
In Sung LEE
Author Information
1. Department of Thoracic and Cardiovascular Surgery, Korea University Medical College.
- Publication Type:Original Article
- Keywords:
Heparin;
Shunt;
Aorta;
Gott
- MeSH:
Adult;
Animals;
Antithrombin III;
Aorta;
Aorta, Thoracic;
Blood Cell Count;
Blood Platelets;
Fibrinogen;
Hemorrhage;
Heparin;
Humans;
Kidney;
Liver;
Partial Thromboplastin Time;
Protein C;
Prothrombin Time;
Thrombin Time;
Thrombosis
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
1999;32(2):97-107
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: This study was designed to develop a Korean version of the heparin-coated vascular bypass shunt by using a physical dispersing technique. The safety and effectiveness of the thrombo-resistant shunt were tested in experimental animals. MATERIAL AND METHOD: A bypass shunt model was constructed on the descending thoracic aorta of 21 adult mongrel dogs(17.5-25 kg). The animals were divided into groups of no-treatment(CONTROL group; n=3), no-treatment with systemic heparinization(HEPARIN group; n=6), Gott heparin shunt (GOTT group; n=6), or Korean heparin shunt(KIST group; n=6). Parameters observed were complete blood cell counts, coagulation profiles, kidney and liver function(BUN/Cr and AST/ ALT), and surface scanning electron microscope(SSEM) findings. Blood was sampled from the aortic blood distal to the shunt and was compared before the bypass and at 2 hours after the bypass. RESULT: There were no differences between the groups before the bypass. At bypass 2 hours, platelet level increased in the HEPARIN and GOTT groups(p<0.05), but there were no differences between the groups. Changes in other blood cell counts were insignificant between the groups. Activated clotting time, activated partial thromboplastin time, and thrombin time were prolonged in the HEPARIN group(p<0.05) and differences between the groups were significant(p<0.005). Prothrombin time increased in the GOTT group(p<0.05) without having any differences between the groups. Changes in fibrinogen level were insignificant between the groups. Antithrombin III levels were increased in the HEPARIN and KIST groups(p<0.05), and the inter-group differences were also significant(p<0.05). Protein C level decreased in the HEPARIN group(p<0.05) without having any differences between the groups. BUN levels increased in all groups, especially in the HEPARIN and KIST groups(p<0.05), but there were no differences between the groups. Changes of Cr, AST, and ALT levels were insignificant between the groups. SSEM findings revealed severe aggregation of platelets and other cellular elements in the CONTROL group, and the HEPARIN group showed more adherence of the cellular elements than the GOTT or KIST group. CONCLUSION: Above results show that the heparin-coated bypass shunts(either GOTT or KIST) can suppress thrombus formation on the surface without inducing bleeding tendencies, while systemic heparinization(HEPARIN) may not be able to block activation of the coagulation system on the surface in contact with foreign materials but increases the bleeding tendencies. We also conclude that the thrombo-resistant effects of the Korean version of heparin shunt(KIST) are similar to those of the commercialized heparin shunt(GOTT).
